生物 肿瘤科学
Minireview
PP2A: Unveiling a Reluctant Tumor Suppressor
Marc Mumby1,*
1
Leading Edge
Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA*Correspondence: marc.mumby@utsouthwestern.eduDOI 10.1016/j.cell.2007.06.034
Although evidence has suggested that the serine/threonine protein phosphatase 2A (PP2A) might be a tumor suppressor protein, it has been difficult to pin down its role in tumor suppression because it acts in a wide variety of signaling pathways. Recent find-ings, including work in this issue by Junttila et al. (2007), provide convincing evidence that suppression of PP2A activity cooperates with other oncogenic changes to cause transfor-mation of multiple cell types.
The unrestricted growth of transformed cells is caused by the cumulative dysregulation of multiple cellular path-ways involved in normal growth control. Although a large number of distinct genetic changes occur in individual cancers, accumulating evidence suggests that a limited number of alterations comprise a core set of changes required for transformation. In human cells, this set of changes includes the expression of telomerase, the acti-vation of Ras, and the inactivation of the tumor suppres-sor proteins RB and p53 (Hanahan and Weinberg, 2000; Hahn and Weinberg 2002). Although these changes are sufficient to immortalize human cells, they do not induce a fully transformed phenotype (as defined by anchorage-independent growth and formation of tumors in immune-deficient mice). Recent evidence indicates that suppres-sion of protein phosphatase 2A (PP2A) activity is an additional alteration needed to push these immortalized cells over the precipice that leads to complete transfor-mation (Junttila et al., 2007; Sablina et al., 2007).
PP2A is a ubiquitously expressed protein serine/thre-onine phosphatase that accounts for a large fraction of phosphatase activity in eukaryotic cells. PP2A is not a single entity but rather a large collection of oligomeric enzymes that contain a common catalytic subunit. The most common forms of PP2A contain an active core dimer composed of the catalytic subunit and a scaffold protein termed the A subunit. The scaffold subunit medi-ates interaction of the core dimer with a wide variety of regulatory subunits (B subunits) that dictate the func-tions of individual forms. Multiple families, isoforms, and splice variants of the regulatory subunits allows genera-tion of over 60 different heterotrimeric PP2A holoen-zymes (Janssens and Goris, 2001). The regulatory sub-units typically enhance the formation of stable complexes between PP2A and its substrates. PP2A has the remark-able ability to interact with structurally distinct regula-tory subunits and to form complexes with many different substrates due to the inherent flexibility of the scaffold subunit, which is composed of 15 tandem HEAT repeats.
The recent solution of the three-dimensional structure of a PP2A holoenzyme has shown that the scaffold subunit undergoes dramatic structural rearrangements follow-ing interaction with the catalytic and regulatory subunits (Xing et al., 2006; Xu et al., 2006; Cho and Xu, 2007). Thus, in addition to diversity generated by the regulatory subunits, flexibility within the PP2A structure provides additional adaptability in substrate recognition. These properties help to account for the large and growing list of phosphoproteins and signaling pathways known to be affected by PP2A.
However, the ubiquitous action of PP2A in many cel-lular processes has been an impediment to defining its role in tumor suppression. Manipulation of the shared catalytic or scaffold subunits (for instance with inhibi-tors) affects the phosphorylation of hundreds, or even thousands, of proteins. An additional complication is that PP2A is essential for viability—complete inhibition of PP2A or loss of the catalytic or scaffold subunits by gene deletion or RNA interference causes cell death. The tumor suppressive function of PP2A has been hiding behind this morass of signaling pathways and the lethal effects of its inhibition. Fortunately, recent advances have begun to tease apart the functions of PP2A in cel-lular transformation and other processes.
The first hint of PP2A’s tumor suppressing activity came from studies in which okadaic acid, a selective but not specific inhibitor of PP2A, was shown to potently promote tumors in a mouse model of carcinogenesis. The second clue came with the discovery that PP2A was the target of the small tumor antigen (small-t) of two transforming DNA viruses, SV40 and polyoma virus (reviewed in Arroyo and Hahn, 2005). Small-t disrupts PP2A by binding to the A subunit and displacing the reg-ulatory subunits but not the catalytic subunit. The result-ing loss in targeting inhibits PP2A activity and enhances phosphorylation of proteins involved in controlling cell growth. However, the role of the interaction between small-t and PP2A in transformation remained uncertain
Cell 130, July 13, 2007 ©2007 Elsevier Inc. 21
These observations identify PP2A Aβ as a tumor suppressor gene that transforms immortalized human cells by regulating the function of RalA. Keywords PP2A; ...
MicroRNA-143 as a Tumor ... 9页 5财富值 PP2A unveiling a relucta......Tumor Suppressor Genes The activation of cellular oncogenes represents only one...
PP2A unveiling a reluc... 4页 4下载券Beclin ...Mutation of the NES of Beclin 1 Blocks Its Tumor Suppressor Function. To...
689409050_Lecture_IV_tum... 暂无评价 79页 免费 PP2A unveiling a relucta... 4页 10财富值喜欢此文档的还喜欢 PTEN tumor suppressor as... 11页 免费搜...
PP2A unveiling a relucta... 4页 10财富值 Loss of the Tumor Suppre... ...a tumor suppressor frequently inactivated in many human cancers, directly antago...
PP2A unveiling a relucta... 4页 10财富值 Loss of the Tumor Suppre... ...a tumor suppressor frequently inactivated in many human cancers, directly antago...
热门文档